Skip to content

Clinical trials

Hyperlipidemias trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Country / region: Italy Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20051
20062
20072
20081
20091
20136
20141
20172
20211
20221
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Unknown status3
Active, not recruiting2
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen4
Pfizer4
Novartis Pharmaceuticals3
AstraZeneca2
Federico II University2
89bio, Inc.1
A. Menarini Industrie Farmaceutiche Riunite S.r.l.1
Bayer1
IBSA Farmaceutici Italia Srl1
Ionis Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias25
Hypercholesterolemia8
Dyslipidemias6
Cardiovascular Diseases4
Diabetes Mellitus3
HIV Infections3
Myocardial Infarction3
Stroke3
Hyperlipoproteinemia Type II2
Hypertension2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.